2023 Conferences
2022 Conferences
2021 Conferences
2020 Conferences
Conferences
“Listen the rhythm, before it pauses”
The Cardiology series of Allied Academies Conferences and its associated journals coordinate welcome the knowledge seekers to immerse themselves in the emerging field of Cardiology. We at Allied Academies, always have the extreme prospective of covering the expansive range of topics in cardiology. The growing enthusiasm for the various fragments of Cardiology and CardiacSurgery has accelerated the Novel Insights of the clinical experiments and the topical comprehensive medication in Cardiological Disorders.
“Does your Heart beats for your Brain and Blood?” 90% of theclinical study has suggested “An Improper Heart Rhythm prior indication of apre mature Heart Failure “.
Outrageous threats like ischemic heart disease,cardiomyopathy, valvular heart disease, vascular disease, hypertension,arrhythmia, congenital heart disease, pharmacological and non-pharmacologicaltreatment of cardiological disease, new diagnostic and Lifesaving techniquesand cardiovascular imaging are the key prospects of the Cardiology Conferencesat Allied Academies Conferences.
The mainframe of Cardiology Conferences is to bring the opportunity to theglobal cardiologists, cardiacsurgeons and researchers to deliver the newer and advance medicalapproaches for the purpose of endeavouring in spreading technical and researchadvances in the clinical, diagnostic and physiological aspects of cardiology.
Each of our Conferences have crammed with Pre ConferenceWorkshop, followed by Keynote Presentation, Oral Presentation, PosterPresentation, and Young Researchers Forum.
We value your time and commitments towards your profession.And it helps us to promote the Video Presentation session and E-Poster sessionfor the Committed Professionals over time and Venue.
Coming to the scope of the cardiology sector, according to anew report the global cardiology market size was valued at USD 116.9 billion in2017 and is expecting a growth of 7.4% over the determined forecast time periodof 2018-2023. Raising of the generality of Congenital Heart Disease and thepresence of technologically advanced cardiac surgery and valves, grafts, &patches are among the fundamental factors expected to drive over the estimatetime frame.
Another WHO report in May 2018, the mortality rate of thepopulation in Japan, UK, USA, Canada, and Australia is due to the increase incardiology diseases. With new drugs and devices entering the market, there israpid innovation in the global cardiology therapeutics market. Diabetes isconsidered one of the leading factors to the current cardiovascular diseaseepidemic, according to a recent report on cardiology market research experts.The growing number of chronic diseases such as diabetes is the major sectionleading to the growth of the cardiology failure market. There will be anexpected growth in the cardiology market in the upcoming years due to thepotential breakthrough of newly authorized drugs in the world market.
The AlliedAcademies Conferences are working boundlessly to deliver the cardiologicscientific progression in an ultimately different level; the world has neverapproached before. So once again we are welcoming all to participants to attendCardiology Conferencesand witness the scientific Evolution in Cardiological medication.
Cardiology Conference | Cardiology Conferences | Arrhythmia Conference | Congenital heart disease Conference | Coronary Artery Disease Conference | Cardiomyopathy Conference | Vascular disease Conference | Stroke Conference | Heart Failure Conference | Hypertension Conference | Rheumatic heart disease | Cardiology Events | Cardiology Meetings
Cardiology is a branch of internal medicine which deals with the most sensitive internal organ heart. Cardiology includes the research of diagnosis, treatment and prevention of the heart diseases and the arteries or veins which are connected to the heart. There are many sub specialities of cardiology such as echocardiography, cardiac electrophysiology, nuclear cardiology and interventional cardiology. As we all know the basic functioning of the blood pump or cardiovascular system includes the path where the heart supplies the oxygen and nutrients in the blood, which is generally called as coronary circulation.
Cardiovascular system consists of a range of disorders which are treated and is been studied in the field of cardiology. In those cases the major one is acute coronary syndrome which has a broad range of spectrum in myocardial infarction symptoms. Few commonly occurring disorders are atherosclerosis, coronary heart disease, Angina pectoris and restenosis. When seen in broader categories of complex disorders in the filed of cardiology includes cardiac arrest, myocardium disorders, spasm of heart tissues, cardiomyopathy, pericardium disorders of heart or swelling in the outer lining of the heart that may include the various types of pericarditis, heart valve diseases which includes aortic valve, mitral valve, pulmonary valve, tricuspid valve etc. Whereas congenital heart defects which are ranging from atrial septal to ventricular sepal defect are the most common ones in the disorders occurring frequently. Diseases of the vascular diseases or blood vessels, in which they include the disorders like deep vein thrombosis, aneurysm, vasculitis, and varicose veins and blood vessels diseases.
Cardiologists are the Specialists in cardiology. Cardiologists uses some of the strategies to combat cardiovascular conditions include percutaneous trans luminal angioplasty, percutaneous coronary intervention, coronary roadway bypass surgery, and stenting. Cardiologists also may diagnose cardiovascular diseases using blood tests, cardiac stress tests, echocardiography or electrocardiography or reckoned tomography and glamorous resonance imaging ways
The global market size of cardiology in 2020 was valued upto 10.11 billion down from nearly 15 billion in 2019 which is due to the hit of covid19 all over the globe. The cardiology global market size was normally expected to reach nearly 18 billion in 2027. In that 45% of global cardiology market size was owned by the companies like Boston Scientific, Abbott and Medtronic. More than 70 countries in the world includes in analysis of 50 interventional cardiology companies jumping right into the market.
COVID19 impact
After the hard hit of covid19 in 2019 the cardiology market got reduced to 25% from 2019 reaching with a valuation of 12.1 billion in 2020. Cardiology market is being expected to increase again after 2022 and will be in steady pace of growth in forthcoming years.
In 2019 million of the patients all around the globe had a delayed care as the hospitals cancelled or postponed non-urgent operations, which is including some of the surgeries for people with heart, kidney and lung conditions. Which as a result, every region around the globe had experienced low numbers of records for the angiographies and the angioplasties in 2020
For an example, in the beautiful city of the Spain, procedures like angioplasty were really very down by 50% within the first two weeks of the lockdown in March and April. But there were also 44.8% low diagnostic examinations and 80.1% fewer procedure like Trans catheter interventions. One of Italy’s worst affected regions Lombardy shuts down 79.8% of the cardiac surgical units in order to preserve their resources for the upcoming emergency in COVID-related cases.
Boston Scientific is one of the leading competitors in the global cardiology market for interventional cardiology devices productions and supply in 2020. This is the company which was the leader of the market in the coronary balloon catheters, coronary embolic protection devices and coronary atherectomy devices markets. The company of Boston Scientific offers the Flextome cutting balloon catheter to the companies like Maverick, Apex, and Emerge PTCA devices.
Abbott was one of the alternate commanding contenders in the global interventional cardiology request. The company held notable positions in the interventional coronary guidewire, coronary stent, FFR guidewire (within the individual coronary catheter and guidewire request), and OCT catheter requests. Medtronic was the third leading contender in the global request in 2020. The company performed the strongest in the interventional coronary catheter request, where it offered the Launcher, Sherpa NX Active, and Sherpa NX Balanced product lines under its portfolio.
Regional insights
Cardiovascular bias is used for the opinion of heart conditions and treatment of affiliated health problems. The cardiovascular bias request is segmented by device type and terrain. On the base of device type, the request is segmented into individual and monitoring bias and remedial and surgical bias. The individual and monitoring bias member is segmented into electrocardiogram (ECG), remote cardiac monitoring, and other individual and monitoring bias. Remedial and surgical bias are segmented into cardiac help bias, cardiac meter operation bias, catheters, grafts, heart faucets, stents, and other remedial and surgical bias. By terrain, the request is segmented into North America, Europe, Asia-Pacific, Middle-East and Africa, and South America. The request report also covers the estimated request sizes and trends for 17 different countries across major regions encyclopaedically. The report offers the value (in USD million) for the below parts.
Leading Cardiology devices manufacturing Companies are
The sector also has good prospects for the future growth, as well. EvaluateMedTech projects that the sector will grow at a compound annual growth rate of 5.1% from 2015 to 2020--one of the healthiest growth rates of any medtech niche.
The sector dominated when it came to the 50% year-over-year increase in PMAs that the medical device industry experienced during the first eight months of 2015, according to EvaluateMedTech (Boston). Worldwide sales in the sector are expected to grow 4.4%, to $54.2 billion, by 2020, with cardiology's share of the global device market ticking up two-tenths of a percentage point to 11.4%.
Cardiology Conference | Cardiology Conferences | Arrhythmia Conference | Congenital heart disease Conference | Coronary Artery Disease Conference | Cardiomyopathy Conference | Vascular disease Conference | Stroke Conference | Heart Failure Conference | Hypertension Conference | Rheumatic heart disease | Cardiology Events | Cardiology Meetings
Here are the 10 companies that Evaluate MedTech expects will lead the cardiology space by 2020, along with descriptions of how their businesses are evolving:
|
Rank |
Company |
2020 Sales (Projected) |
2014 Sales |
% Change |
|
1. |
Medtronic |
$12.001B |
$8.531B |
+3.4% |
|
2. |
St. Jude Medical |
$6.386B |
$4.985B |
+3.6% |
|
3. |
Boston Scientific |
$6.106B |
$5.046B |
+3.3% |
|
4. |
Edwards Lifesciences |
$4.018B |
$3.189B |
+7.5% |
|
5. |
Abbott Laboratories |
$3.219B |
$2.944B |
+1.9% |
|
6. |
Johnson & Johnson |
$2.1200B |
$2.208B |
+2.9% |
|
7. |
Getinge |
$2.014B |
$2.721B |
+3.1% |
|
8. |
Terumo |
$2.002B |
$1.778B |
+4.6% |
|
9. |
W. L. Gore & Associates |
$1.006B |
$1.559B |
+3.7% |
|
10. |
Lepu Medical Technology |
$1.002B |
$201M |
+27.2% |